MENU
SYRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Syros Pharmaceuticals (SYRS) Ownership - Who owns Syros Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
35 CambridgePark Drive
Phone
+1 617 744-1340
Employees
68
Web
https://www.syros.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.61M
P/E Ratio
N/A
Total Cash
58.28M
Projected Growth
N/A
Total Debt
60.23M
Revenue
386K
Risk (Beta)
1.37
Dividend Yield
N/A
Total Cash/Share
2.17
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
SYRS
Capitalization
5.61M
P/E Ratio
N/A
Risk (Beta)
1.37
Dividend Yield
N/A
Total Cash
58.3M
Total Cash/Share
2.17
Total Debt
60.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
386K
ROE
N/A
Book Value
-11.12M
P/B Ratio
11.14
Cash Flow
N/A
Earnings
-3.07
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
27K
Current Ratio
2.25
Current Revenue Per Employee
5676.47
Dividends Per Share - Security
N/A
EBITDA
-91.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-84.04
Shares Held By Institutions
94.3M
Shares Outstanding - Current
26.8M
Total Liabilities
96.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
-97.315
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a therapeutics company focusing on discovering and developing novel gene control therapies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
35 CambridgePark Drive
Phone
+1 617 744-1340
Employees
68
Web
https://www.syros.com